Facial segmental lipoatrophy poses a cosmetic challenge for which various interventions have been explored. This study reports the successful treatment of facial segmental lipoatrophy using a deep priming filler formulation containing calcium hydroxyapatite. The treatment demonstrated effectiveness in restoring facial volume, with notable results sustained over a 12-month period. The incorporation of calcium hydroxyapatite in the filler formulation contributed to enhanced longevity and stability of outcomes. This promising approach represents a valuable option for addressing facial segmental lipoatrophy, offering a long-lasting solution with potential implications for cosmetic dermatology practices. Further research and clinical studies are warranted to validate and extend these findings.
Facial segmental lipoatrophy effectively treated with a deep priming filler incorporating calcium hydroxyapatite with results sustained for 12 months / Proietti, Ilaria; Skroza, Nevena; Tolino, Ersilia; Dybala Agnieszka, Ewa; Potenza, Concetta. - In: JOURNAL OF COSMETIC DERMATOLOGY. - ISSN 1473-2130. - 23:3(2023), pp. 1101-1103. [10.1111/jocd.16083]
Facial segmental lipoatrophy effectively treated with a deep priming filler incorporating calcium hydroxyapatite with results sustained for 12 months
Nevena, Skroza;Ersilia, Tolino;Concetta, Potenza
2023
Abstract
Facial segmental lipoatrophy poses a cosmetic challenge for which various interventions have been explored. This study reports the successful treatment of facial segmental lipoatrophy using a deep priming filler formulation containing calcium hydroxyapatite. The treatment demonstrated effectiveness in restoring facial volume, with notable results sustained over a 12-month period. The incorporation of calcium hydroxyapatite in the filler formulation contributed to enhanced longevity and stability of outcomes. This promising approach represents a valuable option for addressing facial segmental lipoatrophy, offering a long-lasting solution with potential implications for cosmetic dermatology practices. Further research and clinical studies are warranted to validate and extend these findings.File | Dimensione | Formato | |
---|---|---|---|
Proietti_Facial-segmental_2023.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
1.17 MB
Formato
Adobe PDF
|
1.17 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.